» Articles » PMID: 24465134

Microvascular Pericytes in Healthy and Diseased Kidneys

Overview
Publisher Dove Medical Press
Specialty Nephrology
Date 2014 Jan 28
PMID 24465134
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Pericytes are interstitial mesenchymal cells found in many major organs. In the kidney, microvascular pericytes are defined anatomically as extensively branched, collagen-producing cells in close contact with endothelial cells. Although many molecular markers have been proposed, none of them can identify the pericytes with satisfactory specificity or sensitivity. The roles of microvascular pericytes in kidneys were poorly understood in the past. Recently, by using genetic lineage tracing to label collagen-producing cells or mesenchymal cells, the elusive characteristics of the pericytes have been illuminated. The purpose of this article is to review recent advances in the understanding of microvascular pericytes in the kidneys. In healthy kidney, the pericytes are found to take part in the maintenance of microvascular stability. Detachment of the pericytes from the microvasculature and loss of the close contact with endothelial cells have been observed during renal insult. Renal microvascular pericytes have been shown to be the major source of scar-forming myofibroblasts in fibrogenic kidney disease. Targeting the crosstalk between pericytes and neighboring endothelial cells or tubular epithelial cells may inhibit the pericyte-myofibroblast transition, prevent peritubular capillary rarefaction, and attenuate renal fibrosis. In addition, renal pericytes deserve attention for their potential to produce erythropoietin in healthy kidneys as pericytes stand in the front line, sensing the change of oxygenation and hemoglobin concentration. Further delineation of the mechanisms underlying the reduced erythropoietin production occurring during pericyte-myofibroblast transition may be promising for the development of new treatment strategies for anemia in chronic kidney disease.

Citing Articles

Research advances in cochlear pericytes and hearing loss.

Shi X Hear Res. 2023; 438:108877.

PMID: 37651921 PMC: 10538405. DOI: 10.1016/j.heares.2023.108877.


Heterogeneity of Platelet Derived Growth Factor Pathway Gene Expression Profile Defines Three Distinct Subgroups of Renal Cell Carcinomas.

Ferician A, Ferician O, Cumpanas A, Berzava P, Nesiu A, Barmayoun A Cancer Genomics Proteomics. 2022; 19(4):477-489.

PMID: 35732321 PMC: 9247877. DOI: 10.21873/cgp.20334.


Certainties and uncertainties concerning the contribution of pericytes to the pathogenesis of systemic sclerosis.

Talotta R, Atzeni F, Ditto M, Gerardi M, Batticciotto A, Bongiovanni S J Scleroderma Relat Disord. 2022; 3(1):14-20.

PMID: 35382121 PMC: 8892870. DOI: 10.5301/jsrd.5000254.


Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF-β signaling in kidney fibroblasts.

Chen Y, Jhao P, Hung C, Wu Y, Lin S, Chiang W J Clin Invest. 2021; 131(5).

PMID: 33465051 PMC: 7919722. DOI: 10.1172/JCI143645.


Acoustic Trauma Causes Cochlear Pericyte-to-Myofibroblast-Like Cell Transformation and Vascular Degeneration, and Transplantation of New Pericytes Prevents Vascular Atrophy.

Hou Z, Neng L, Zhang J, Cai J, Wang X, Zhang Y Am J Pathol. 2020; 190(9):1943-1959.

PMID: 32562655 PMC: 7450261. DOI: 10.1016/j.ajpath.2020.05.019.


References
1.
Hung C, Linn G, Chow Y, Kobayashi A, Mittelsteadt K, Altemeier W . Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med. 2013; 188(7):820-30. PMC: 3826269. DOI: 10.1164/rccm.201212-2297OC. View

2.
Duffield J, Park K, Hsiao L, Kelley V, Scadden D, Ichimura T . Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest. 2005; 115(7):1743-55. PMC: 1159124. DOI: 10.1172/JCI22593. View

3.
Souma T, Yamazaki S, Moriguchi T, Suzuki N, Hirano I, Pan X . Plasticity of renal erythropoietin-producing cells governs fibrosis. J Am Soc Nephrol. 2013; 24(10):1599-616. PMC: 3785278. DOI: 10.1681/ASN.2013010030. View

4.
Eddy A . The origin of scar-forming kidney myofibroblasts. Nat Med. 2013; 19(8):964-6. DOI: 10.1038/nm.3299. View

5.
Hung S, Lin Y, Tarng D . Erythropoiesis-stimulating agents in chronic kidney disease: what have we learned in 25 years?. J Formos Med Assoc. 2013; 113(1):3-10. DOI: 10.1016/j.jfma.2013.09.004. View